JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus has maintained a Neutral rating on Zimmer Biomet Holdings (NYSE:ZBH) and lowered the price target from $146 to $115.
November 08, 2023 | 8:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan has maintained a Neutral rating on Zimmer Biomet Holdings and lowered the price target from $146 to $115.
The lowering of the price target by JP Morgan indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100